NCT04627467View on ClinicalTrials.gov

Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID)

PHASE2CompletedINTERVENTIONAL

Enrollment

3,217

Participants

Timeline

Start Date

March 28, 2020

Primary Completion Date

July 9, 2020

Study Completion Date

September 30, 2021

Conditions

Covid19

Interventions

DRUG

Chloroquine

250mg tablet (150mg base chloroquine)

Trial Locations (1)

760032

Fundacion Valle del Lili, Santiago de Cali

All Listed Sponsors

lead

Fundacion Clinica Valle del Lili

OTHER

NCT04627467 - Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID) | Biotech Hunter | Biotech Hunter